Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Medical Devices & Consumables > Murine Monoclonal Antibody- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Murine Monoclonal Antibody- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Murine Monoclonal Antibody- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Devices & Consumables

Published: 2026-03-10

Pages: 118 Pages

Report ld: 6117364

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global market for Murine Monoclonal Antibody was estimated to be worth US$ 14 million in 2025 and is projected to reach US$ 30.62 million, growing at a CAGR of 12.0% from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Murine Monoclonal Antibody cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Murine Monoclonal Antibody Market Size(US$)

M= millions and B=billions

QYRLogo
Mouse-derived monoclonal antibodies are antibodies with single specificity and a homogeneous structure prepared using the mouse immune system and hybridoma technology. The basic principle involves fusing immunized mouse spleen cells with myeloma cells, screening for hybridoma cell lines that secrete antibodies against specific antigens, thereby achieving unlimited proliferation and stable production of antibodies. Mouse-derived monoclonal antibodies are characterized by high specificity, high affinity, and good batch-to-batch stability, and are widely used in biomedical research, disease diagnosis, vaccine development, and early screening of antibody drugs. However, because they are entirely derived from mice, they may trigger immune rejection reactions (HAMA reactions) in human applications. Therefore, in the development of therapeutic antibodies, they are often used as templates for further optimization of chimeric or humanized antibodies.Sales volume in 2024 is expected to be 125,000 units, with an average price of US$95 per unit.The single-line production capacity is 20,000 units, and the gross profit margin is 85%.

Despite the increasing maturity of humanized and fully human antibody technologies, mouse monoclonal antibodies (mAbs) remain a stable cornerstone of basic life science research and the in vitro diagnostics (IVD) reagent market. In research, mouse models are the most mature and economical platform for developing and producing new antibodies; their high specificity and affinity make them the gold standard tool for studying protein function, cellular pathways, and disease mechanisms. In IVD, due to their high batch-to-batch stability and low preparation cost, mouse antibodies are key capture or detection antibodies for constructing immunoassay kits (such as ELISA and rapid diagnostic reagents), ensuring the reliability and cost-effectiveness of products in large-scale applications.

In drug development and therapeutics, mouse monoclonal antibodies face market application limitations due to their high immunogenicity (easily triggering the human HAMA response, i.e., the human anti-mouse antibody response), and have been largely replaced by chimeric, humanized, or fully human antibodies. However, this does not mean that mouse monoclonal antibodies are obsolete, but rather that their value realization has changed. The value of mouse monoclonal antibodies in drug development lies in their role as "initial discovery" and "lead candidate": they serve as the starting point for screening new targets and validating antibody efficacy. Through subsequent genetic engineering techniques (such as chimerism and CDR transplantation), the specific binding regions of mouse antibodies can be transferred to human frameworks, extending their value and commercializing them in the clinical treatment market.

This report provides a comprehensive view of the global market for Murine Monoclonal Antibody, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Murine Monoclonal Antibody market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Murine Monoclonal Antibody.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Murine Monoclonal Antibody- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

  • Forecasted Market Size in 2032

  • US$ 30.62 million

  • CAGR(2026-2032)

  • 12.0%

  • Market Size Available for Years

  • 2026-2032

  • Global Murine Monoclonal Antibody Companies Covered

  • Thermo Fisher Scientific

    Promega Corporation

    New England Biolabs

    Roche

    QIAGEN GmbH

    Merck

    Bio-Rad Laboratories

    AMSBIO

    TIANGEN Biotech

    Amyjet Scientific

    Vazyme Biotech

    Bioer Technology

    Yeasen

    RayBiotech, Inc.

    Enzynomics

  • Global Murine Monoclonal Antibody Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Murine Monoclonal Antibody Market, Segment by Type

  • 2KU

    10KU

    20KU

    100KU

    Others

  • Global Murine Monoclonal Antibody Market, Segment by Application

  • Biopharmaceutical Laboratories

    University Laboratories

    Others

  • Product Category

  • Mouse IgG1 Monoclonal Antibody

    Mouse IgG2a Monoclonal Antibody

    Others

  • Market Segment

  • Hybridoma-derived Monoclonal Antibody

    Recombinant Mouse Monoclonal Antibody

    Phage Display-derived Mouse Monoclonal Antibody

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Murine Monoclonal Antibody manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Murine Monoclonal Antibody sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Murine Monoclonal Antibody sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Murine Monoclonal Antibody Product Introduction
    1.2 Global Murine Monoclonal Antibody Market Size Forecast
        1.2.1 Global Murine Monoclonal Antibody Sales Value (2021–2032)
        1.2.2 Global Murine Monoclonal Antibody Sales Volume (2021–2032)
        1.2.3 Global Murine Monoclonal Antibody Sales Price (2021–2032)
    1.3 Murine Monoclonal Antibody Market Trends & Drivers
        1.3.1 Murine Monoclonal Antibody Industry Trends
        1.3.2 Murine Monoclonal Antibody Market Drivers & Opportunities
        1.3.3 Murine Monoclonal Antibody Market Challenges
        1.3.4 Murine Monoclonal Antibody Market Restraints
        1.3.5 Impact of U.S. Tariffs
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global Murine Monoclonal Antibody Players Revenue Ranking (2025)
    2.2 Global Murine Monoclonal Antibody Revenue by Company (2021–2026)
    2.3 Global Murine Monoclonal Antibody Sales Volume Ranking of Players (2025)
    2.4 Global Murine Monoclonal Antibody Sales Volume by Company (2021–2026)
    2.5 Global Murine Monoclonal Antibody Average Price by Company (2021–2026)
    2.6 Key Manufacturers Murine Monoclonal Antibody Manufacturing Base and Headquarters
    2.7 Key Manufacturers Murine Monoclonal Antibody Product Offerings
    2.8 Key Manufacturers Start of Mass Production of Murine Monoclonal Antibody
    2.9 Murine Monoclonal Antibody Market Competitive Analysis
        2.9.1 Murine Monoclonal Antibody Market Concentration Rate (2021–2026)
        2.9.2 Global 5 and 10 Largest Manufacturers by Murine Monoclonal Antibody Revenue in 2025
        2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Murine Monoclonal Antibody revenue, 2025
    2.10 Mergers & Acquisitions and Expansion
3 Segmentation Murine Monoclonal Antibody Market Classification
    3.1 Introduction by Type
        3.1.1 2KU
        3.1.2 10KU
        3.1.3 20KU
        3.1.4 100KU
        3.1.5 Others
        3.1.6 Global Murine Monoclonal Antibody Sales Value by Type
            3.1.6.1 Global Murine Monoclonal Antibody Sales Value by Type (2021 vs 2025 vs 2032)
            3.1.6.2 Global Murine Monoclonal Antibody Sales Value, by Type (2021–2032)
            3.1.6.3 Global Murine Monoclonal Antibody Sales Value, by Type (%), 2021–2032
        3.1.7 Global Murine Monoclonal Antibody Sales Volume by Type
            3.1.7.1 Global Murine Monoclonal Antibody Sales Volume by Type (2021 vs 2025 vs 2032)
            3.1.7.2 Global Murine Monoclonal Antibody Sales Volume, by Type (2021–2032)
            3.1.7.3 Global Murine Monoclonal Antibody Sales Volume, by Type (%), 2021–2032
        3.1.8 Global Murine Monoclonal Antibody Average Price by Type (2021–2032)
    3.2 Introduction by Structure and Isotype
        3.2.1 Mouse IgG1 Monoclonal Antibody
        3.2.2 Mouse IgG2a Monoclonal Antibody
        3.2.3 Others
        3.2.4 Global Murine Monoclonal Antibody Sales Value by Structure and Isotype
            3.2.4.1 Global Murine Monoclonal Antibody Sales Value by Structure and Isotype (2021 vs 2025 vs 2032)
            3.2.4.2 Global Murine Monoclonal Antibody Sales Value, by Structure and Isotype (2021–2032)
            3.2.4.3 Global Murine Monoclonal Antibody Sales Value, by Structure and Isotype (%), 2021–2032
        3.2.5 Global Murine Monoclonal Antibody Sales Volume by Structure and Isotype
            3.2.5.1 Global Murine Monoclonal Antibody Sales Volume by Structure and Isotype (2021 vs 2025 vs 2032)
            3.2.5.2 Global Murine Monoclonal Antibody Sales Volume, by Structure and Isotype (2021–2032)
            3.2.5.3 Global Murine Monoclonal Antibody Sales Volume, by Structure and Isotype (%), 2021–2032
        3.2.6 Global Murine Monoclonal Antibody Average Price by Structure and Isotype (2021–2032)
    3.3 Introduction by Production Method
        3.3.1 Hybridoma-derived Monoclonal Antibody
        3.3.2 Recombinant Mouse Monoclonal Antibody
        3.3.3 Phage Display-derived Mouse Monoclonal Antibody
        3.3.4 Global Murine Monoclonal Antibody Sales Value by Production Method
            3.3.4.1 Global Murine Monoclonal Antibody Sales Value by Production Method (2021 vs 2025 vs 2032)
            3.3.4.2 Global Murine Monoclonal Antibody Sales Value, by Production Method (2021–2032)
            3.3.4.3 Global Murine Monoclonal Antibody Sales Value, by Production Method (%), 2021–2032
        3.3.5 Global Murine Monoclonal Antibody Sales Volume by Production Method
            3.3.5.1 Global Murine Monoclonal Antibody Sales Volume by Production Method (2021 vs 2025 vs 2032)
            3.3.5.2 Global Murine Monoclonal Antibody Sales Volume, by Production Method (2021–2032)
            3.3.5.3 Global Murine Monoclonal Antibody Sales Volume, by Production Method (%), 2021–2032
        3.3.6 Global Murine Monoclonal Antibody Average Price by Production Method (2021–2032)
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Biopharmaceutical Laboratories
        4.1.2 University Laboratories
        4.1.3 Others
    4.2 Global Murine Monoclonal Antibody Sales Value by Application
        4.2.1 Global Murine Monoclonal Antibody Sales Value by Application (2021 vs 2025 vs 2032)
        4.2.2 Global Murine Monoclonal Antibody Sales Value, by Application (2021–2032)
        4.2.3 Global Murine Monoclonal Antibody Sales Value, by Application (%), 2021–2032
    4.3 Global Murine Monoclonal Antibody Sales Volume by Application
        4.3.1 Global Murine Monoclonal Antibody Sales Volume by Application (2021 vs 2025 vs 2032)
        4.3.2 Global Murine Monoclonal Antibody Sales Volume, by Application (2021–2032)
        4.3.3 Global Murine Monoclonal Antibody Sales Volume, by Application (%), 2021–2032
    4.4 Global Murine Monoclonal Antibody Average Price by Application (2021–2032)
5 Segmentation by Region
    5.1 Global Murine Monoclonal Antibody Sales Value by Region
        5.1.1 Global Murine Monoclonal Antibody Sales Value by Region: 2021 vs 2025 vs 2032
        5.1.2 Global Murine Monoclonal Antibody Sales Value by Region (2021–2026)
        5.1.3 Global Murine Monoclonal Antibody Sales Value by Region (2027–2032)
        5.1.4 Global Murine Monoclonal Antibody Sales Value by Region (%), 2021–2032
    5.2 Global Murine Monoclonal Antibody Sales Volume by Region
        5.2.1 Global Murine Monoclonal Antibody Sales Volume by Region: 2021 vs 2025 vs 2032
        5.2.2 Global Murine Monoclonal Antibody Sales Volume by Region (2021–2026)
        5.2.3 Global Murine Monoclonal Antibody Sales Volume by Region (2027–2032)
        5.2.4 Global Murine Monoclonal Antibody Sales Volume by Region (%), 2021–2032
    5.3 Global Murine Monoclonal Antibody Average Price by Region (2021–2032)
    5.4 North America
        5.4.1 North America Murine Monoclonal Antibody Sales Value, 2021–2032
        5.4.2 North America Murine Monoclonal Antibody Sales Value by Country (%), 2025 vs 2032
    5.5 Europe
        5.5.1 Europe Murine Monoclonal Antibody Sales Value, 2021–2032
        5.5.2 Europe Murine Monoclonal Antibody Sales Value by Country (%), 2025 vs 2032
    5.6 Asia Pacific
        5.6.1 Asia Pacific Murine Monoclonal Antibody Sales Value, 2021–2032
        5.6.2 Asia Pacific Murine Monoclonal Antibody Sales Value by Region (%), 2025 vs 2032
    5.7 South America
        5.7.1 South America Murine Monoclonal Antibody Sales Value, 2021–2032
        5.7.2 South America Murine Monoclonal Antibody Sales Value by Country (%), 2025 vs 2032
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Murine Monoclonal Antibody Sales Value, 2021–2032
        5.8.2 Middle East & Africa Murine Monoclonal Antibody Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Murine Monoclonal Antibody Sales Value Growth Trends, 2021 vs 2025 vs 2032
    6.2 Key Countries/Regions Murine Monoclonal Antibody Sales Value and Sales Volume
        6.2.1 Key Countries/Regions Murine Monoclonal Antibody Sales Value, 2021–2032
        6.2.2 Key Countries/Regions Murine Monoclonal Antibody Sales Volume, 2021–2032
    6.3 United States
        6.3.1 United States Murine Monoclonal Antibody Sales Value, 2021–2032
        6.3.2 United States Murine Monoclonal Antibody Sales Value by Type (%), 2025 vs 2032
        6.3.3 United States Murine Monoclonal Antibody Sales Value by Application, 2025 vs 2032
    6.4 Europe
        6.4.1 Europe Murine Monoclonal Antibody Sales Value, 2021–2032
        6.4.2 Europe Murine Monoclonal Antibody Sales Value by Type (%), 2025 vs 2032
        6.4.3 Europe Murine Monoclonal Antibody Sales Value by Application, 2025 vs 2032
    6.5 China
        6.5.1 China Murine Monoclonal Antibody Sales Value, 2021–2032
        6.5.2 China Murine Monoclonal Antibody Sales Value by Type (%), 2025 vs 2032
        6.5.3 China Murine Monoclonal Antibody Sales Value by Application, 2025 vs 2032
    6.6 Japan
        6.6.1 Japan Murine Monoclonal Antibody Sales Value, 2021–2032
        6.6.2 Japan Murine Monoclonal Antibody Sales Value by Type (%), 2025 vs 2032
        6.6.3 Japan Murine Monoclonal Antibody Sales Value by Application, 2025 vs 2032
    6.7 South Korea
        6.7.1 South Korea Murine Monoclonal Antibody Sales Value, 2021–2032
        6.7.2 South Korea Murine Monoclonal Antibody Sales Value by Type (%), 2025 vs 2032
        6.7.3 South Korea Murine Monoclonal Antibody Sales Value by Application, 2025 vs 2032
    6.8 Southeast Asia
        6.8.1 Southeast Asia Murine Monoclonal Antibody Sales Value, 2021–2032
        6.8.2 Southeast Asia Murine Monoclonal Antibody Sales Value by Type (%), 2025 vs 2032
        6.8.3 Southeast Asia Murine Monoclonal Antibody Sales Value by Application, 2025 vs 2032
    6.9 India
        6.9.1 India Murine Monoclonal Antibody Sales Value, 2021–2032
        6.9.2 India Murine Monoclonal Antibody Sales Value by Type (%), 2025 vs 2032
        6.9.3 India Murine Monoclonal Antibody Sales Value by Application, 2025 vs 2032
7 Company Profiles
    7.1 Thermo Fisher Scientific
        7.1.1 Thermo Fisher Scientific Company Information
        7.1.2 Thermo Fisher Scientific Introduction and Business Overview
        7.1.3 Thermo Fisher Scientific Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.1.4 Thermo Fisher Scientific Murine Monoclonal Antibody Product Offerings
        7.1.5 Thermo Fisher Scientific Recent Developments
    7.2 Promega Corporation
        7.2.1 Promega Corporation Company Information
        7.2.2 Promega Corporation Introduction and Business Overview
        7.2.3 Promega Corporation Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.2.4 Promega Corporation Murine Monoclonal Antibody Product Offerings
        7.2.5 Promega Corporation Recent Developments
    7.3 New England Biolabs
        7.3.1 New England Biolabs Company Information
        7.3.2 New England Biolabs Introduction and Business Overview
        7.3.3 New England Biolabs Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.3.4 New England Biolabs Murine Monoclonal Antibody Product Offerings
        7.3.5 New England Biolabs Recent Developments
    7.4 Roche
        7.4.1 Roche Company Information
        7.4.2 Roche Introduction and Business Overview
        7.4.3 Roche Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.4.4 Roche Murine Monoclonal Antibody Product Offerings
        7.4.5 Roche Recent Developments
    7.5 QIAGEN GmbH
        7.5.1 QIAGEN GmbH Company Information
        7.5.2 QIAGEN GmbH Introduction and Business Overview
        7.5.3 QIAGEN GmbH Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.5.4 QIAGEN GmbH Murine Monoclonal Antibody Product Offerings
        7.5.5 QIAGEN GmbH Recent Developments
    7.6 Merck
        7.6.1 Merck Company Information
        7.6.2 Merck Introduction and Business Overview
        7.6.3 Merck Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.6.4 Merck Murine Monoclonal Antibody Product Offerings
        7.6.5 Merck Recent Developments
    7.7 Bio-Rad Laboratories
        7.7.1 Bio-Rad Laboratories Company Information
        7.7.2 Bio-Rad Laboratories Introduction and Business Overview
        7.7.3 Bio-Rad Laboratories Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.7.4 Bio-Rad Laboratories Murine Monoclonal Antibody Product Offerings
        7.7.5 Bio-Rad Laboratories Recent Developments
    7.8 AMSBIO
        7.8.1 AMSBIO Company Information
        7.8.2 AMSBIO Introduction and Business Overview
        7.8.3 AMSBIO Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.8.4 AMSBIO Murine Monoclonal Antibody Product Offerings
        7.8.5 AMSBIO Recent Developments
    7.9 TIANGEN Biotech
        7.9.1 TIANGEN Biotech Company Information
        7.9.2 TIANGEN Biotech Introduction and Business Overview
        7.9.3 TIANGEN Biotech Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.9.4 TIANGEN Biotech Murine Monoclonal Antibody Product Offerings
        7.9.5 TIANGEN Biotech Recent Developments
    7.10 Amyjet Scientific
        7.10.1 Amyjet Scientific Company Information
        7.10.2 Amyjet Scientific Introduction and Business Overview
        7.10.3 Amyjet Scientific Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.10.4 Amyjet Scientific Murine Monoclonal Antibody Product Offerings
        7.10.5 Amyjet Scientific Recent Developments
    7.11 Vazyme Biotech
        7.11.1 Vazyme Biotech Company Information
        7.11.2 Vazyme Biotech Introduction and Business Overview
        7.11.3 Vazyme Biotech Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.11.4 Vazyme Biotech Murine Monoclonal Antibody Product Offerings
        7.11.5 Vazyme Biotech Recent Developments
    7.12 Bioer Technology
        7.12.1 Bioer Technology Company Information
        7.12.2 Bioer Technology Introduction and Business Overview
        7.12.3 Bioer Technology Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.12.4 Bioer Technology Murine Monoclonal Antibody Product Offerings
        7.12.5 Bioer Technology Recent Developments
    7.13 Yeasen
        7.13.1 Yeasen Company Information
        7.13.2 Yeasen Introduction and Business Overview
        7.13.3 Yeasen Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.13.4 Yeasen Murine Monoclonal Antibody Product Offerings
        7.13.5 Yeasen Recent Developments
    7.14 RayBiotech, Inc.
        7.14.1 RayBiotech, Inc. Company Information
        7.14.2 RayBiotech, Inc. Introduction and Business Overview
        7.14.3 RayBiotech, Inc. Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.14.4 RayBiotech, Inc. Murine Monoclonal Antibody Product Offerings
        7.14.5 RayBiotech, Inc. Recent Developments
    7.15 Enzynomics
        7.15.1 Enzynomics Company Information
        7.15.2 Enzynomics Introduction and Business Overview
        7.15.3 Enzynomics Murine Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021–2026)
        7.15.4 Enzynomics Murine Monoclonal Antibody Product Offerings
        7.15.5 Enzynomics Recent Developments
8 Industry Chain Analysis
    8.1 Murine Monoclonal Antibody Industrial Chain
    8.2 Murine Monoclonal Antibody Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Key Suppliers of Raw Materials
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customer Analysis)
    8.5 Sales Model and Sales Channelss
        8.5.1 Murine Monoclonal Antibody Sales Model
        8.5.2 Sales Channels
        8.5.3 Murine Monoclonal Antibody Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Murine Monoclonal Antibody Market Trends
 Table 2. Murine Monoclonal Antibody Market Drivers & Opportunities
 Table 3. Murine Monoclonal Antibody Market Challenges
 Table 4. Murine Monoclonal Antibody Market Restraints
 Table 5. Global Murine Monoclonal Antibody Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Murine Monoclonal Antibody Revenue Market Share by Company (2021–2026)
 Table 7. Global Murine Monoclonal Antibody Sales Volume by Company (K Units), 2021–2026
 Table 8. Global Murine Monoclonal Antibody Sales Volume Market Share by Company (2021–2026)
 Table 9. Global Market Murine Monoclonal Antibody Price by Company (US$/Unit), 2021–2026
 Table 10. Key Manufacturers Murine Monoclonal Antibody Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Murine Monoclonal Antibody Product Type
 Table 12. Key Manufacturers Start of Mass Production of Murine Monoclonal Antibody
 Table 13. Global Murine Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Murine Monoclonal Antibody revenue, 2025
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Murine Monoclonal Antibody Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Murine Monoclonal Antibody Sales Value by Type (US$ Million), 2021–2026
 Table 18. Global Murine Monoclonal Antibody Sales Value by Type (US$ Million), 2027–2032
 Table 19. Global Murine Monoclonal Antibody Sales Market Share in Value by Type (2021–2026)
 Table 20. Global Murine Monoclonal Antibody Sales Market Share in Value by Type (2027–2032)
 Table 21. Global Murine Monoclonal Antibody Sales Volume by Type: 2021 vs 2025 vs 2032 (K Units)
 Table 22. Global Murine Monoclonal Antibody Sales Volume by Type (K Units), 2021–2026
 Table 23. Global Murine Monoclonal Antibody Sales Volume by Type (K Units), 2027–2032
 Table 24. Global Murine Monoclonal Antibody Sales Market Share in Volume by Type (2021–2026)
 Table 25. Global Murine Monoclonal Antibody Sales Market Share in Volume by Type (2027–2032)
 Table 26. Global Murine Monoclonal Antibody Price by Type (US$/Unit), 2021–2026
 Table 27. Global Murine Monoclonal Antibody Price by Type (US$/Unit), 2027–2032
 Table 28. Global Murine Monoclonal Antibody Sales Value by Structure and Isotype: 2021 vs 2025 vs 2032 (US$ Million)
 Table 29. Global Murine Monoclonal Antibody Sales Value by Structure and Isotype (US$ Million), 2021–2026
 Table 30. Global Murine Monoclonal Antibody Sales Value by Structure and Isotype (US$ Million), 2027–2032
 Table 31. Global Murine Monoclonal Antibody Sales Market Share in Value by Structure and Isotype (2021–2026)
 Table 32. Global Murine Monoclonal Antibody Sales Market Share in Value by Structure and Isotype (2027–2032)
 Table 33. Global Murine Monoclonal Antibody Sales Volume by Structure and Isotype: 2021 vs 2025 vs 2032 (K Units)
 Table 34. Global Murine Monoclonal Antibody Sales Volume by Structure and Isotype (K Units), 2021–2026
 Table 35. Global Murine Monoclonal Antibody Sales Volume by Structure and Isotype (K Units), 2027–2032
 Table 36. Global Murine Monoclonal Antibody Sales Market Share in Volume by Structure and Isotype (2021–2026)
 Table 37. Global Murine Monoclonal Antibody Sales Market Share in Volume by Structure and Isotype (2027–2032)
 Table 38. Global Murine Monoclonal Antibody Price by Structure and Isotype (US$/Unit), 2021–2026
 Table 39. Global Murine Monoclonal Antibody Price by Structure and Isotype (US$/Unit), 2027–2032
 Table 40. Global Murine Monoclonal Antibody Sales Value by Production Method: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Global Murine Monoclonal Antibody Sales Value by Production Method (US$ Million), 2021–2026
 Table 42. Global Murine Monoclonal Antibody Sales Value by Production Method (US$ Million), 2027–2032
 Table 43. Global Murine Monoclonal Antibody Sales Market Share in Value by Production Method (2021–2026)
 Table 44. Global Murine Monoclonal Antibody Sales Market Share in Value by Production Method (2027–2032)
 Table 45. Global Murine Monoclonal Antibody Sales Volume by Production Method: 2021 vs 2025 vs 2032 (K Units)
 Table 46. Global Murine Monoclonal Antibody Sales Volume by Production Method (K Units), 2021–2026
 Table 47. Global Murine Monoclonal Antibody Sales Volume by Production Method (K Units), 2027–2032
 Table 48. Global Murine Monoclonal Antibody Sales Market Share in Volume by Production Method (2021–2026)
 Table 49. Global Murine Monoclonal Antibody Sales Market Share in Volume by Production Method (2027–2032)
 Table 50. Global Murine Monoclonal Antibody Price by Production Method (US$/Unit), 2021–2026
 Table 51. Global Murine Monoclonal Antibody Price by Production Method (US$/Unit), 2027–2032
 Table 52. Global Murine Monoclonal Antibody Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 53. Global Murine Monoclonal Antibody Sales Value by Application (US$ Million), 2021–2026
 Table 54. Global Murine Monoclonal Antibody Sales Value by Application (US$ Million), 2027–2032
 Table 55. Global Murine Monoclonal Antibody Sales Market Share in Value by Application (2021–2026)
 Table 56. Global Murine Monoclonal Antibody Sales Market Share in Value by Application (2027–2032)
 Table 57. Global Murine Monoclonal Antibody Sales Volume by Application: 2021 vs 2025 vs 2032 (K Units)
 Table 58. Global Murine Monoclonal Antibody Sales Volume by Application (K Units), 2021–2026
 Table 59. Global Murine Monoclonal Antibody Sales Volume by Application (K Units), 2027–2032
 Table 60. Global Murine Monoclonal Antibody Sales Market Share in Volume by Application (2021–2026)
 Table 61. Global Murine Monoclonal Antibody Sales Market Share in Volume by Application (2027–2032)
 Table 62. Global Murine Monoclonal Antibody Price by Application (US$/Unit), 2021–2026
 Table 63. Global Murine Monoclonal Antibody Price by Application (US$/Unit), 2027–2032
 Table 64. Global Murine Monoclonal Antibody Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 65. Global Murine Monoclonal Antibody Sales Value by Region (US$ Million), 2021–2026
 Table 66. Global Murine Monoclonal Antibody Sales Value by Region (US$ Million), 2027–2032
 Table 67. Global Murine Monoclonal Antibody Sales Value by Region (%), 2021–2026
 Table 68. Global Murine Monoclonal Antibody Sales Value by Region (%), 2027–2032
 Table 69. Global Murine Monoclonal Antibody Sales Volume by Region (K Units): 2021 vs 2025 vs 2032
 Table 70. Global Murine Monoclonal Antibody Sales Volume by Region (K Units), 2021–2026
 Table 71. Global Murine Monoclonal Antibody Sales Volume by Region (K Units), 2027–2032
 Table 72. Global Murine Monoclonal Antibody Sales Volume by Region (%), 2021–2026
 Table 73. Global Murine Monoclonal Antibody Sales Volume by Region (%), 2027–2032
 Table 74. Global Murine Monoclonal Antibody Average Price by Region (US$/Unit), 2021–2026
 Table 75. Global Murine Monoclonal Antibody Average Price by Region (US$/Unit), 2027–2032
 Table 76. Key Countries/Regions Murine Monoclonal Antibody Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 77. Key Countries/Regions Murine Monoclonal Antibody Sales Value, (US$ Million), 2021–2026
 Table 78. Key Countries/Regions Murine Monoclonal Antibody Sales Value, (US$ Million), 2027–2032
 Table 79. Key Countries/Regions Murine Monoclonal Antibody Sales Volume, (K Units), 2021–2026
 Table 80. Key Countries/Regions Murine Monoclonal Antibody Sales Volume, (K Units), 2027–2032
 Table 81. Thermo Fisher Scientific Company Information
 Table 82. Thermo Fisher Scientific Introduction and Business Overview
 Table 83. Thermo Fisher Scientific Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 84. Thermo Fisher Scientific Murine Monoclonal Antibody Product Offerings
 Table 85. Thermo Fisher Scientific Recent Developments
 Table 86. Promega Corporation Company Information
 Table 87. Promega Corporation Introduction and Business Overview
 Table 88. Promega Corporation Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 89. Promega Corporation Murine Monoclonal Antibody Product Offerings
 Table 90. Promega Corporation Recent Developments
 Table 91. New England Biolabs Company Information
 Table 92. New England Biolabs Introduction and Business Overview
 Table 93. New England Biolabs Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 94. New England Biolabs Murine Monoclonal Antibody Product Offerings
 Table 95. New England Biolabs Recent Developments
 Table 96. Roche Company Information
 Table 97. Roche Introduction and Business Overview
 Table 98. Roche Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 99. Roche Murine Monoclonal Antibody Product Offerings
 Table 100. Roche Recent Developments
 Table 101. QIAGEN GmbH Company Information
 Table 102. QIAGEN GmbH Introduction and Business Overview
 Table 103. QIAGEN GmbH Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 104. QIAGEN GmbH Murine Monoclonal Antibody Product Offerings
 Table 105. QIAGEN GmbH Recent Developments
 Table 106. Merck Company Information
 Table 107. Merck Introduction and Business Overview
 Table 108. Merck Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 109. Merck Murine Monoclonal Antibody Product Offerings
 Table 110. Merck Recent Developments
 Table 111. Bio-Rad Laboratories Company Information
 Table 112. Bio-Rad Laboratories Introduction and Business Overview
 Table 113. Bio-Rad Laboratories Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 114. Bio-Rad Laboratories Murine Monoclonal Antibody Product Offerings
 Table 115. Bio-Rad Laboratories Recent Developments
 Table 116. AMSBIO Company Information
 Table 117. AMSBIO Introduction and Business Overview
 Table 118. AMSBIO Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 119. AMSBIO Murine Monoclonal Antibody Product Offerings
 Table 120. AMSBIO Recent Developments
 Table 121. TIANGEN Biotech Company Information
 Table 122. TIANGEN Biotech Introduction and Business Overview
 Table 123. TIANGEN Biotech Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 124. TIANGEN Biotech Murine Monoclonal Antibody Product Offerings
 Table 125. TIANGEN Biotech Recent Developments
 Table 126. Amyjet Scientific Company Information
 Table 127. Amyjet Scientific Introduction and Business Overview
 Table 128. Amyjet Scientific Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 129. Amyjet Scientific Murine Monoclonal Antibody Product Offerings
 Table 130. Amyjet Scientific Recent Developments
 Table 131. Vazyme Biotech Company Information
 Table 132. Vazyme Biotech Introduction and Business Overview
 Table 133. Vazyme Biotech Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 134. Vazyme Biotech Murine Monoclonal Antibody Product Offerings
 Table 135. Vazyme Biotech Recent Developments
 Table 136. Bioer Technology Company Information
 Table 137. Bioer Technology Introduction and Business Overview
 Table 138. Bioer Technology Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 139. Bioer Technology Murine Monoclonal Antibody Product Offerings
 Table 140. Bioer Technology Recent Developments
 Table 141. Yeasen Company Information
 Table 142. Yeasen Introduction and Business Overview
 Table 143. Yeasen Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 144. Yeasen Murine Monoclonal Antibody Product Offerings
 Table 145. Yeasen Recent Developments
 Table 146. RayBiotech, Inc. Company Information
 Table 147. RayBiotech, Inc. Introduction and Business Overview
 Table 148. RayBiotech, Inc. Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 149. RayBiotech, Inc. Murine Monoclonal Antibody Product Offerings
 Table 150. RayBiotech, Inc. Recent Developments
 Table 151. Enzynomics Company Information
 Table 152. Enzynomics Introduction and Business Overview
 Table 153. Enzynomics Murine Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 154. Enzynomics Murine Monoclonal Antibody Product Offerings
 Table 155. Enzynomics Recent Developments
 Table 156. Key Raw Materials Lists
 Table 157. Key Suppliers of Raw Materials Lists
 Table 158. Murine Monoclonal Antibody Downstream Customers
 Table 159. Murine Monoclonal Antibody Distributors List
 Table 160. Research Programs/Design for This Report
 Table 161. Key Data Information from Secondary Sources
 Table 162. Key Data Information from Primary Sources


List of Figures
 Figure 1. Murine Monoclonal Antibody Product Picture
 Figure 2. Global Murine Monoclonal Antibody Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Murine Monoclonal Antibody Sales Value (US$ Million), 2021–2032
 Figure 4. Global Murine Monoclonal Antibody Sales Volume (K Units), 2021–2032
 Figure 5. Global Murine Monoclonal Antibody Sales Price (US$/Unit), 2021–2032
 Figure 6. Murine Monoclonal Antibody Report Years Considered
 Figure 7. Global Murine Monoclonal Antibody Players Revenue Ranking (US$ Million), 2025
 Figure 8. Global Murine Monoclonal Antibody Sales Volume Ranking of Players (K Units), 2025
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Murine Monoclonal Antibody Revenue in 2025
 Figure 10. Murine Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 11. 2KU Picture
 Figure 12. 10KU Picture
 Figure 13. 20KU Picture
 Figure 14. 100KU Picture
 Figure 15. Others Picture
 Figure 16. Global Murine Monoclonal Antibody Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Murine Monoclonal Antibody Sales Value Market Share by Type, 2025 & 2032
 Figure 18. Global Murine Monoclonal Antibody Sales Volume by Type (K Units), 2021 vs 2025 vs 2032
 Figure 19. Global Murine Monoclonal Antibody Sales Volume Market Share by Type, 2025 & 2032
 Figure 20. Global Murine Monoclonal Antibody Price by Type (US$/Unit), 2021–2032
 Figure 21. Mouse IgG1 Monoclonal Antibody Picture
 Figure 22. Mouse IgG2a Monoclonal Antibody Picture
 Figure 23. Others Picture
 Figure 24. Global Murine Monoclonal Antibody Sales Value by Structure and Isotype (US$ Million), 2021 vs 2025 vs 2032
 Figure 25. Global Murine Monoclonal Antibody Sales Value Market Share by Structure and Isotype, 2025 & 2032
 Figure 26. Global Murine Monoclonal Antibody Sales Volume by Structure and Isotype (K Units), 2021 vs 2025 vs 2032
 Figure 27. Global Murine Monoclonal Antibody Sales Volume Market Share by Structure and Isotype, 2025 & 2032
 Figure 28. Global Murine Monoclonal Antibody Price by Structure and Isotype (US$/Unit), 2021–2032
 Figure 29. Hybridoma-derived Monoclonal Antibody Picture
 Figure 30. Recombinant Mouse Monoclonal Antibody Picture
 Figure 31. Phage Display-derived Mouse Monoclonal Antibody Picture
 Figure 32. Global Murine Monoclonal Antibody Sales Value by Production Method (US$ Million), 2021 vs 2025 vs 2032
 Figure 33. Global Murine Monoclonal Antibody Sales Value Market Share by Production Method, 2025 & 2032
 Figure 34. Global Murine Monoclonal Antibody Sales Volume by Production Method (K Units), 2021 vs 2025 vs 2032
 Figure 35. Global Murine Monoclonal Antibody Sales Volume Market Share by Production Method, 2025 & 2032
 Figure 36. Global Murine Monoclonal Antibody Price by Production Method (US$/Unit), 2021–2032
 Figure 37. Product Picture of Biopharmaceutical Laboratories
 Figure 38. Product Picture of University Laboratories
 Figure 39. Product Picture of Others
 Figure 40. Global Murine Monoclonal Antibody Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 41. Global Murine Monoclonal Antibody Sales Value Market Share by Application, 2025 & 2032
 Figure 42. Global Murine Monoclonal Antibody Sales Volume by Application (K Units), 2021 vs 2025 vs 2032
 Figure 43. Global Murine Monoclonal Antibody Sales Volume Market Share by Application, 2025 & 2032
 Figure 44. Global Murine Monoclonal Antibody Price by Application (US$/Unit), 2021–2032
 Figure 45. North America Murine Monoclonal Antibody Sales Value (US$ Million), 2021–2032
 Figure 46. North America Murine Monoclonal Antibody Sales Value by Country (%), 2025 vs 2032
 Figure 47. Europe Murine Monoclonal Antibody Sales Value (US$ Million), 2021–2032
 Figure 48. Europe Murine Monoclonal Antibody Sales Value by Country (%), 2025 vs 2032
 Figure 49. Asia Pacific Murine Monoclonal Antibody Sales Value (US$ Million), 2021–2032
 Figure 50. Asia Pacific Murine Monoclonal Antibody Sales Value by Region (%), 2025 vs 2032
 Figure 51. South America Murine Monoclonal Antibody Sales Value (US$ Million), 2021–2032
 Figure 52. South America Murine Monoclonal Antibody Sales Value by Country (%), 2025 vs 2032
 Figure 53. Middle East & Africa Murine Monoclonal Antibody Sales Value (US$ Million), 2021–2032
 Figure 54. Middle East & Africa Murine Monoclonal Antibody Sales Value by Country (%), 2025 vs 2032
 Figure 55. Key Countries/Regions Murine Monoclonal Antibody Sales Value (%), 2021–2032
 Figure 56. Key Countries/Regions Murine Monoclonal Antibody Sales Volume (%), 2021–2032
 Figure 57. United States Murine Monoclonal Antibody Sales Value (US$ Million), 2021–2032
 Figure 58. United States Murine Monoclonal Antibody Sales Value by Type (%), 2025 vs 2032
 Figure 59. United States Murine Monoclonal Antibody Sales Value by Application (%), 2025 vs 2032
 Figure 60. Europe Murine Monoclonal Antibody Sales Value (US$ Million), 2021–2032
 Figure 61. Europe Murine Monoclonal Antibody Sales Value by Type (%), 2025 vs 2032
 Figure 62. Europe Murine Monoclonal Antibody Sales Value by Application (%), 2025 vs 2032
 Figure 63. China Murine Monoclonal Antibody Sales Value (US$ Million), 2021–2032
 Figure 64. China Murine Monoclonal Antibody Sales Value by Type (%), 2025 vs 2032
 Figure 65. China Murine Monoclonal Antibody Sales Value by Application (%), 2025 vs 2032
 Figure 66. Japan Murine Monoclonal Antibody Sales Value (US$ Million), 2021–2032
 Figure 67. Japan Murine Monoclonal Antibody Sales Value by Type (%), 2025 vs 2032
 Figure 68. Japan Murine Monoclonal Antibody Sales Value by Application (%), 2025 vs 2032
 Figure 69. South Korea Murine Monoclonal Antibody Sales Value (US$ Million), 2021–2032
 Figure 70. South Korea Murine Monoclonal Antibody Sales Value by Type (%), 2025 vs 2032
 Figure 71. South Korea Murine Monoclonal Antibody Sales Value by Application (%), 2025 vs 2032
 Figure 72. Southeast Asia Murine Monoclonal Antibody Sales Value (US$ Million), 2021–2032
 Figure 73. Southeast Asia Murine Monoclonal Antibody Sales Value by Type (%), 2025 vs 2032
 Figure 74. Southeast Asia Murine Monoclonal Antibody Sales Value by Application (%), 2025 vs 2032
 Figure 75. India Murine Monoclonal Antibody Sales Value (US$ Million), 2021–2032
 Figure 76. India Murine Monoclonal Antibody Sales Value by Type (%), 2025 vs 2032
 Figure 77. India Murine Monoclonal Antibody Sales Value by Application (%), 2025 vs 2032
 Figure 78. Murine Monoclonal Antibody Industrial Chain
 Figure 79. Murine Monoclonal Antibody Manufacturing Cost Structure
 Figure 80. Channels of Distribution (Direct Sales, and Distribution)
 Figure 81. Bottom-up and Top-down Approaches for This Report
 Figure 82. Data Triangulation
 Figure 83. Key Executives Interviewed

Description

The global market for Murine Monoclonal Antibody was estimated to be worth US$ 14 million in 2025 and is projected to reach US$ 30.62 million, growing at a CAGR of 12.0% from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Murine Monoclonal Antibody cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Mouse-derived monoclonal antibodies are antibodies with single specificity and a homogeneous structure prepared using the mouse immune system and hybridoma technology. The basic principle involves fusing immunized mouse spleen cells with myeloma cells, screening for hybridoma cell lines that secrete antibodies against specific antigens, thereby achieving unlimited proliferation and stable production of antibodies. Mouse-derived monoclonal antibodies are characterized by high specificity, high affinity, and good batch-to-batch stability, and are widely used in biomedical research, disease diagnosis, vaccine development, and early screening of antibody drugs. However, because they are entirely derived from mice, they may trigger immune rejection reactions (HAMA reactions) in human applications. Therefore, in the development of therapeutic antibodies, they are often used as templates for further optimization of chimeric or humanized antibodies.Sales volume in 2024 is expected to be 125,000 units, with an average price of US$95 per unit.The single-line production capacity is 20,000 units, and the gross profit margin is 85%.

Despite the increasing maturity of humanized and fully human antibody technologies, mouse monoclonal antibodies (mAbs) remain a stable cornerstone of basic life science research and the in vitro diagnostics (IVD) reagent market. In research, mouse models are the most mature and economical platform for developing and producing new antibodies; their high specificity and affinity make them the gold standard tool for studying protein function, cellular pathways, and disease mechanisms. In IVD, due to their high batch-to-batch stability and low preparation cost, mouse antibodies are key capture or detection antibodies for constructing immunoassay kits (such as ELISA and rapid diagnostic reagents), ensuring the reliability and cost-effectiveness of products in large-scale applications.

In drug development and therapeutics, mouse monoclonal antibodies face market application limitations due to their high immunogenicity (easily triggering the human HAMA response, i.e., the human anti-mouse antibody response), and have been largely replaced by chimeric, humanized, or fully human antibodies. However, this does not mean that mouse monoclonal antibodies are obsolete, but rather that their value realization has changed. The value of mouse monoclonal antibodies in drug development lies in their role as "initial discovery" and "lead candidate": they serve as the starting point for screening new targets and validating antibody efficacy. Through subsequent genetic engineering techniques (such as chimerism and CDR transplantation), the specific binding regions of mouse antibodies can be transferred to human frameworks, extending their value and commercializing them in the clinical treatment market.

This report provides a comprehensive view of the global market for Murine Monoclonal Antibody, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Murine Monoclonal Antibody market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Murine Monoclonal Antibody.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Murine Monoclonal Antibody manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Murine Monoclonal Antibody sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Murine Monoclonal Antibody sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.

Related Reports

Murine Monoclonal Antibody- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Devices & Consumables

Published: 2026-03-10

Pages: 118 Pages

Report ld: 6117364

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now